News & Events
SKLMN advocates scientific dissemination and provides a platform for academic exchange, collaboration and dissemination of new findings.
Mr. Wang Zhigang, the Minister of Science and Technology, led a delegation to visit the State Key Laboratory of Molecular Neuroscience (HKUST) on 22 September 2018. Prof. Nancy and the research team introduced the latest findings to the delegates.
The Partner State Key Laboratories in Hong Kong was renamed into State Key Laboratories to have higher flexibility in collaborating with different research and development institutions. In a ceremony held on 20 September 2018, Mr. Wang Zhigang, the Minister of Science and Technology, presented the plaque to Professor Nancy Ip, Director of the State Key Laboratory of Molecular Neuroscience (HKUST).
A Joint Annual Meeting and Symposium between the SKL Molecular Neuroscience (HKUST) and the SKL Neuroscience (Shanghai) was held from 14 to 15 December 2016 in Shanghai, with the participation of 25 speakers from the two institutions. With a program of presentations and panel discussions, the joint meeting offered the ideal environment for scientific exchange, and strengthened collaborative efforts between the two Laboratories.
In partnership with the Alzheimer's Association of the United States, members of the SKL organized the Croucher Advanced Study Institute “Alzheimer's Dementia in a Global Context” at HKUST from 10 to 13 January 2015. The purpose of the workshop is to showcase new advances in Alzheimer's disease (AD) research, while hosting the event at an Asian venue provides the opportunity to review the similarities and differences between Eastern and Western perspectives on the disease. AD experts from Hong Kong, China, Europe, and North America were invited to give lectures about their latest discoveries, discuss their cultural and scientific experiences, review the most up-to-date developments, offer their views on current problems, and engage in three days of intensive discussion. This unique format of the workshop provides a platform to promote Hong Kong's cutting-edge biomedical research as well as highlight its role in the global quest for developing effective medicines to help improve the quality of life of AD patients.